Surrogate Endpoints: Wishful Thinking or Reality?
Open Access
- 19 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (8) , 502-503
- https://doi.org/10.1093/jnci/djj153
Abstract
More than 100 years ago, the noted French mathematician Henri Poincaré quoted the following remark about the assumption of a normal distribution: “Everybody firmly believes in it because the mathematicians imagine it is a fact of observation, and observers that it is a theory of mathematics” ( 1 ) . A similar generalization could be made about methods to validate surrogate endpoints: Biostatisticians believe that the methods they propose are useful because clinicians adopt them, and clinicians believe that the methods proposed by biostatisticians are useful because they have the “imprimatur” of mathematical statistics. Given this state of affairs, a critical examination of methods to validate surrogate endpoints is needed.Keywords
This publication has 10 references indexed in Scilit:
- Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16JNCI Journal of the National Cancer Institute, 2006
- A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpointBiostatistics, 2005
- Statistical evaluation of biomarkers as surrogate endpoints: a literature reviewStatistics in Medicine, 2005
- Estimating the proportion of treatment effect explained by a surrogate marker by D. Y. Lin, T. R. Fleming and V. De Gruttola,Statistics in Medicine,16, 1515-1527 (1997)Statistics in Medicine, 1999
- Criteria for the Validation of Surrogate Endpoints in Randomized ExperimentsPublished by JSTOR ,1998
- ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKERStatistics in Medicine, 1997
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- Lognormal DistributionsNature, 1945